Write your message
Articles In Press : Volume 06 - Issue 04 (Fall 07-2021 - Serial : 23)                   Back to the articles list | Back to browse issues page

XML Print

1- Department of Obstetrics and Gynecology, Isfahan University of Medical Sciences, Isfahan, Iran
2- Department of Obstetrics and Gynecology, Isfahan University of Medical Sciences, Isfahan, Iran , Maryamdehghan.1367md@gmail.com
Abstract:   (47 Views)

Background & Objective: The objective of this study was to evaluate colposcopic, endocervical curettage (ECC) and endometrial curettage (EMC) findings in comparison with Pap smears findings.
Materials & Methods: Out of 100,000 Pap smears, a total number of 75 eligible women with atypical glandular cells (AGCs) referred to gynecology clinics in Isfahan, Iran, and seventy women were selected to undergo Pap smear test, colposcopic examination and ECC. EMC was performed in women older than 35. Pap smear test results were classified as normal, inflammation, AGCs and necrosis. Colposcopy, ECC and EMC findings were classified as normal, benign and malignant pathologic lesions.
Results: Repetitive Pap smears findings were as follows: 15.7% were normal, 77.2% had inflammation, 4% had AGC and 3.1% had necrosis. Based on colposcopy findings, 61.2%, 7.5%, and 31.3% of the samples were classified as normal, benign and malignant, respectively. ECC findings in 95.5% of women was indicative of benign lesions and malignant lesions in 4.5%. EMC findings showed that 79.7% were normal, 8.5% had benign lesions and 11.9% had malignant lesions. Pap smears with several AGCs were associated with benign lesions in 24.2% of the cases and premalignant and malignant lesions in 14.2% of the cases.
Conclusion: According to our study, due to the significant association between AGC cytology and pathologic cervical and endometrial lesions, intensive assessment is necessary in women with AGC Pap smears, especially in older and post-menopausal women, in order to reduce mortality.

Systematic Review: Original Research | Subject: Obstetrics and Gynecology
Received: 2021/03/18 | Accepted: 2021/05/27

1. Olusola P, Banerjee HN, Philley JV, Dasgupta S. Human Papilloma Virus-Associated Cervical Cancer and Health Disparities. Cells. 2019;8(6). [DOI:10.3390/cells8060622]
2. Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL. Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol. 2018;151(3):547-54. [DOI:10.1016/j.ygyno.2018.10.004]
3. Han L, Chang X, Song P, Gao L, Zhang Y, An L, et al. An on-going study of three different cervical cancer screening strategies based on primary healthcare facilities in Beijing China. J Infect Public Health. 2020;13(4):577-83. [DOI:10.1016/j.jiph.2019.09.003]
4. Kacperczyk J, Bartnik P, Romejko-Wolniewicz E, Jalinik K. Results of Further Diagnostic Procedures Among Patients with Cytological Characteristics of Minor Changes on Pap Smears. Anticancer Res. 2016;36(3):1023-6.
5. Schiffman M, Solomon D. Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting. New Engl J Med. 2013;369(24):2324-31. [DOI:10.1056/NEJMcp1210379]
6. Macharia H, Cheserem EJ, Bukusi E, Muchiri L. A comparative analysis of conventional Pap smear cytology, liquid based cytology and colposcopy clinical impression with colposcopy biopsy histology as gold standard in women undergoing colposcopy in Kenyatta National Hospital. Int J Reprod, Contracept, Obstet Gynecol. 2014;3(1):58-63.
7. Boyraz G, Basaran D, Salman MC, Ibrahimov A, Onder S, Akman O, et al. Histological Follow-Up in Patients with Atypical Glandular Cells on Pap Smears. J Cytol. 2017;34(4):203-7. [DOI:10.4103/JOC.JOC_209_16]
8. Marques JPdH, Costa LB, Pinto APdSe, Lima AFd, Duarte MEL, Barbosa APF, et al. Células glandulares atípicas e câncer de colo uterino: revisão sistemática. Revista da Associação Médica Brasileira. 2011;57:234-8. [DOI:10.1590/S0104-42302011000200024]
9. Jeng CJ LH, Wang TY, Shen J, Yang YC, Tzeng CR. Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening. Int J Gynecol Cancer. 2003;13(4):518-21. https://doi.org/10.1046/j.1525-1438.2003.13182.x [DOI:10.1136/ijgc-00009577-200307000-00018]
10. Schorge JO, Rauh-Hain JA. Atypical glandular cells. Clin Obstet Gynecol. 2013;56(1):35-43. [DOI:10.1097/GRF.0b013e3182823849]
11. Chin AB, Bristow RE, Korst LM, Walts A, Lagasse LD. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Am J Obstet Gynecol. 2000;182(6):1278-82. [DOI:10.1067/mob.2000.106537]
12. Jeng CJ, Liang HS, Wang TY, Shen J, Yang YC, Tzeng CR. Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening. Int J Gynecol Cancer. 2003;13(4):518-21. https://doi.org/10.1046/j.1525-1438.2003.13182.x [DOI:10.1136/ijgc-00009577-200307000-00018]
13. Lee CY, Ng WK. Follow-up study of atypical glandular cells in gynecologic cytology using conventional Pap smears and liquid-based preparations: impact of the Bethesda System 2001. Acta Cytol. 2008;52(2):159-68. [DOI:10.1159/000325474]
14. Westin MC, Derchain SF, Rabelo-Santos SH, Angelo-Andrade LA, Sarian LO, Oliveira E, et al. Atypical glandular cells and adenocarcinoma in situ according to the Bethesda 2001 classification: cytohistological correlation and clinical implications. Eur J Obstet Gynecol Reprod Biol. 2008;139(1):79-85. [DOI:10.1016/j.ejogrb.2007.08.017]
15. Akhter S, Bari A, Hayat Z. Variability study between Pap smear, Colposcopy and Cervical Histopathology findings. J Pak Med Assoc. 2015;65(12):1295-9.
16. Wang J, Andrae B, Sundström K, Ström P, Ploner A, Elfström KM, et al. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study. Bmj. 2016;352:i276. [DOI:10.1136/bmj.i276]
17. Saad RS, Takei H, Liu YL, Silverman JE, Lipscomb JT, Ruiz B. Clinical significance of a cytologic diagnosis of atypical glandular cells, favor endometrial origin, in Pap smears. Acta Cytol. 2006;50(1):48-54. [DOI:10.1159/000325894]
18. Kim MK, Lee YK, Hong SR, Lim KT. Clinicopathological significance of atypical glandular cells on cervicovaginal Pap smears. Diagn Cytopathol. 2017;45(10):867-72. [DOI:10.1002/dc.23777]
19. Pradhan D, Li Z, Ocque R, Patadji S, Zhao C. Clinical significance of atypical glandular cells in Pap tests: An analysis of more than 3000 cases at a large academic women's center. Cancer Cytopathol. 2016;124(8):589-95. [DOI:10.1002/cncy.21724]
20. Dasari P, Rajathi S, Kumar SV. Colposcopic evaluation of cervix with persistent inflammatory Pap smear: A prospective analytical study. Cytojournal. 2010;7:16. [DOI:10.4103/1742-6413.67112]
21. Melinte-Popescu A, Costăchescu G. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis. Rev Med Chir Soc Med Nat Iasi. 2012;116(2):536-9.
22. Gadre SS, Gupta SG, Gadre AS. Descriptive analytical study looking for agreement between colposcopic cervical findings and cervical exfoliative cytology. Int J Reprod Contracept Obstet Gynecol. 2013;2(3):402-5.
23. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360-3.

Add your comments about this article : Your username or Email:

Send email to the article author

© 2021 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.